Aurobindo Pharma on Saturday said it has inked a pact to acquire Portugal’s Generis Farmaceutica SA from Magnum Capital Partners for a consideration of 135 million euros (around Rs 969 crore).
The company has inked a binding agreement through its wholly-owned subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica for a total consideration of 135 million euros, Aurobindo Pharma said in a statement.
Generis produces and sells pharma products in Portugal
With the latest acquisition, Aurobindo will now have a portfolio of 271 products in the European nation.
The Hyderabad-based firm has been steadily expanding its European footprint since 2006. In 2014 it has acquired Actavis’s commercial operations in seven Western European countries.